Quick Takeaways
- Cheryl Gault has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,566,024.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Cheryl Gault
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Cheryl Gault is at least $4,566,024 dollars as of 31 Mar 2026. Cheryl Gault is the Chief Operating Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $4.57M.
- Signature
- /s/ Troy Ignelzi, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Cheryl Gault and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Rapport Therapeutics, Inc. ($4,566,024).
- Past-year value change for that position: -$490,609.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Cheryl Gault
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Chief Operating Officer | $4,566,024 | -$490,609 | -9.7% | 30 Mar 2026 |
| CYCN | Cyclerion Therapeutics, Inc. | Chief Operating Officer | 20 Jan 2022 |
Insider Transactions Reported by Cheryl Gault:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.